ADPT Adaptive Biotechnologies Corp

Price (delayed)

$34

Market cap

$4.79B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.23

Enterprise value

$4.71B

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Adaptive Biotechnologies believes the ...

Highlights
The revenue has grown by 45% YoY and by 15% from the previous quarter
The gross profit has grown by 43% year-on-year and by 13% since the previous quarter
ADPT's equity is up by 31% year-on-year but it is down by 4.5% since the previous quarter
ADPT's debt has surged by 137% year-on-year and by 9% since the previous quarter
ADPT's EPS has dropped by 86% year-on-year and by 8% since the previous quarter

Key stats

What are the main financial stats of ADPT
Market
Shares outstanding
140.77M
Market cap
$4.79B
Enterprise value
$4.71B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.88
Price to sales (P/S)
35.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
35.29
Earnings
Revenue
$133.43M
EBIT
-$169.43M
EBITDA
-$153.95M
Free cash flow
-$233.92M
Per share
EPS
-$1.23
Free cash flow per share
-$1.67
Book value per share
$4.94
Revenue per share
$0.95
TBVPS
$6.45
Balance sheet
Total assets
$1.03B
Total liabilities
$340.06M
Debt
$108.61M
Equity
$693.18M
Working capital
$527.08M
Liquidity
Debt to equity
0.16
Current ratio
5.52
Quick ratio
5.27
Net debt/EBITDA
0.5
Margins
EBITDA margin
-115.4%
Gross margin
75.2%
Net margin
-128.3%
Operating margin
-129.2%
Efficiency
Return on assets
-15.9%
Return on equity
-23.3%
Return on invested capital
-24.7%
Return on capital employed
-18.5%
Return on sales
-127%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ADPT stock price

How has the Adaptive Biotechnologies stock price performed over time
Intraday
1.07%
1 week
6.32%
1 month
-6.82%
1 year
-31.31%
YTD
-42.5%
QTD
0.03%

Financial performance

How have Adaptive Biotechnologies's revenue and profit performed over time
Revenue
$133.43M
Gross profit
$100.4M
Operating income
-$172.33M
Net income
-$171.23M
Gross margin
75.2%
Net margin
-128.3%
The company's net income has shrunk by 72% YoY and by 10% QoQ
Adaptive Biotechnologies's operating income has shrunk by 51% YoY and by 8% QoQ
The revenue has grown by 45% YoY and by 15% from the previous quarter
The gross profit has grown by 43% year-on-year and by 13% since the previous quarter

Growth

What is Adaptive Biotechnologies's growth rate over time

Valuation

What is Adaptive Biotechnologies stock price valuation
P/E
N/A
P/B
6.88
P/S
35.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
35.29
ADPT's EPS has dropped by 86% year-on-year and by 8% since the previous quarter
ADPT's equity is up by 31% year-on-year but it is down by 4.5% since the previous quarter
ADPT's P/B is 22% below its last 4 quarters average of 8.8
The revenue has grown by 45% YoY and by 15% from the previous quarter
ADPT's price to sales (P/S) is 41% lower than its last 4 quarters average of 60.2

Efficiency

How efficient is Adaptive Biotechnologies business performance
Adaptive Biotechnologies's ROA has decreased by 42% YoY and by 6% from the previous quarter
The ROE has decreased by 31% YoY and by 4% QoQ
The ROIC has contracted by 28% YoY but it has grown by 6% from the previous quarter
ADPT's return on sales is down by 16% year-on-year but it is up by 5% since the previous quarter

Dividends

What is ADPT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ADPT.

Financial health

How did Adaptive Biotechnologies financials performed over time
The quick ratio has declined by 24% since the previous quarter and by 15% year-on-year
The current ratio has contracted by 23% from the previous quarter and by 14% YoY
ADPT's debt is 84% smaller than its equity
ADPT's debt has surged by 137% year-on-year and by 9% since the previous quarter
ADPT's debt to equity has surged by 78% year-on-year and by 14% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.